Post-approval studies (Phase 4)Study completedNCT00190411
What this trial is testing
Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
Who this might be right for
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANTCHROMOSOME 2q31.2 DELETION SYNDROME
Assistance Publique - Hôpitaux de Paris 54